Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients
- 28 November 2006
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 103 (48), 18066-18071
- https://doi.org/10.1073/pnas.0608853103
Abstract
Cancer/testis (CT) antigens are immunogenic proteins expressed in normal gametogenic tissues and in different types of tumors. CT antigens are promising candidates for cancer immunotherapy, and the identification of novel CT antigens is a prerequisite for the development of cancer vaccines. We have identified a CT antigen, named CTSP-1, with partial similarity to the breast differentiation antigen NY-BR-1. CTSIP-1 presents several splicing and polyadenylation variants and has a very restricted expression pattern among normal tissues. CTSP-1 is exclusively expressed in normal testis and is aberrantly expressed in 47.6% (10 of 21) of tumor cell lines and in 44.4% (75 of 169) of tumors from different histological types. The highest percentages of positive expression were observed in melanomas (59.0%) followed by prostate (58.0%) and lung (57.0%) tumors. CTSP-1 is part of a highly conserved gene family, and members of this family also have a restricted expression pattern and similar protein structure. Antibodies against members of this gene family were detected in 10% (14 of 141) of plasma samples from patients with a wide spectrum of tumors. The highest percentages of antibody response were observed in patients with prostate (20.8%), thyroid (20.0%), and breast (16.6%) tumors. Because of its very restricted expression pattern in normal tissues and immunogenicity in different types of tumors, CTSIP-1 should be considered a promising candidate for cancer immunotherapy.Keywords
This publication has 35 references indexed in Scilit:
- Human retroelements may introduce intragenic polyadenylation signalsCytogenetic and Genome Research, 2005
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast TumorsCancer Research, 2004
- The Pfam protein families databaseNucleic Acids Research, 2004
- Cancer/testis‐associated genes: Identification, expression profile, and putative functionJournal of Cellular Physiology, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapyExpert Opinion on Biological Therapy, 2002
- BLAT—The BLAST-Like Alignment ToolGenome Research, 2002
- Recognition of melanoma cell antigens with antibodies present in sera from patients with vitiligoInternational Journal of Dermatology, 2000
- Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopesFertility and Sterility, 1997